AQR Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

AQR Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,898,656	Closed	-$66.1M	–	2545
2014 Q4	$66.1M	Buy	3,898,656 +3,820,856	+4,911%	+$53.8M	0.14%	205
2014 Q3	$927K	Sell	77,800 -75,000	-49%	-$512K	﹤0.01%	1650
2014 Q2	$862K	Sell	152,800 -6,200	-4%	-$28.6K	﹤0.01%	1719
2014 Q1	$584K	Buy	159,000 +20,800	+15%	+$79.3K	﹤0.01%	1962
2013 Q4	$464K	Buy	138,200 +63,300	+85%	+$261K	﹤0.01%	2105
2013 Q3	$318K	Buy	+74,900	New	+$355K	﹤0.01%	2186

AQR Capital Management's AVNR Position: Q1 2015 in Review

AQR Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 3,898,656 shares — an estimated $66.1M sold.

AQR Capital Management first reported a position in AVNR in Q3 2013 and held it in 6 quarters. The position peaked at $66.1M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

AQR Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
AQR Capital Management sold 3,898,656 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $66.1M.
AQR Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 6 quarters.
AQR Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $66.1M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on AQR Capital Management's 13F filing for Q1 2015, filed 15 May 2015.